Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

NEW YORK, Oct. 17, 2018 /PRNewswire/ — Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU Summary Read the full report: https://www.reportlinker.com/p05588760 Market access of oncology medicines is increasingly challenging due to the rising cost of new and…

Source: https://www.prnewswire.com:443/news-releases/market-access-pricing-and-reimbursement-of-oncology-medicines-in-the-5eu-300732984.html